Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 129,500 | 55,900 | 173,900 | 114,500 | 70,700 |
| Depreciation Amortization | 39,500 | 19,400 | 75,200 | 58,300 | 39,100 |
| Income taxes - deferred | 11,200 | 10,000 | 23,500 | -14,800 | -20,000 |
| Accounts receivable | -41,000 | -20,600 | 13,600 | 4,300 | -21,200 |
| Accounts payable and accrued liabilities | 40,800 | 45,400 | 4,200 | 22,800 | 11,200 |
| Other Working Capital | -67,900 | -27,200 | -46,400 | -50,500 | -69,100 |
| Other Operating Activity | -6,800 | -21,600 | -213,400 | -165,200 | -80,100 |
| Operating Cash Flow | $105,300 | $61,300 | $30,600 | $-30,600 | $-69,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -121,600 | -63,800 | -304,900 | -219,900 | -127,100 |
| Other Investing Activity | -100 | -100 | 1,017,000 | 1,017,000 | 1,010,600 |
| Investing Cash Flow | $-121,700 | $-63,900 | $712,100 | $797,100 | $883,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,200 | 2,200 | 2,200 |
| Debt Issued | 300 | 200 | 634,100 | 634,000 | 633,800 |
| Debt Repayment | -300 | -300 | -658,200 | -658,200 | -657,800 |
| Common Stock Issued | 9,900 | 8,100 | 23,500 | 21,300 | 13,600 |
| Common Stock Repurchased | N/A | N/A | -750,100 | -750,100 | -642,000 |
| Dividend Paid | -8,900 | -4,500 | -21,500 | -17,100 | -12,600 |
| Other Financing Activity | 4,400 | 3,800 | 5,500 | 4,500 | 2,800 |
| Financing Cash Flow | $5,400 | $7,300 | $-764,500 | $-763,400 | $-660,000 |
| Exchange Rate Effect | -600 | 300 | -5,700 | -5,800 | -5,700 |
| Beginning Cash Position | 151,800 | 151,800 | 179,300 | 179,300 | 179,300 |
| End Cash Position | 140,200 | 156,800 | 151,800 | 176,600 | 327,700 |
| Net Cash Flow | $-11,600 | $5,000 | $-27,500 | $-2,700 | $148,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 105,300 | 61,300 | 30,600 | -30,600 | -69,400 |
| Capital Expenditure | -121,600 | -63,800 | -304,900 | -219,900 | -127,100 |
| Free Cash Flow | -16,300 | -2,500 | -274,300 | -250,500 | -196,500 |